| DRRX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the DRRX shares outstanding history going back to 2/26/2010:
Also see: DRRX Market Cap History DRRX YTD Return |
DRRX Shares Outstanding History — Durect Share Count Over Time
As of 8/8/2025 Durect has 31.05 million DRRX shares outstanding. Investors often track the DRRX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows DRRX share count trends over time, with 56 historical shares outstanding datapoints presented, dating back to 2/26/2010.
| DRRX Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DRRX Historical Shares Outstanding: +8.60% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DRRX Stock Price Chart |
| About Durect Corp |
| DURECT Corporation is a late-stage biopharmaceutical company pioneering the development of epigenetic therapies that target dysregulated deoxyribonucleic acid (DNA) methylation to transform the treatment of serious and life-threatening conditions, including acute organ injury and cancer. Larsucosterol is in clinical development for the potential treatment of alcohol-associated hepatitis, for which U.S. Food and Drug Administration (FDA) has granted a Fast Track Designation; metabolic dysfunction-associated steatohepatitis is also being explored. We show 56 historical shares outstanding datapoints in our coverage of DRRX's shares outstanding history. Understanding the changing numbers of DRRX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like DRRX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching DRRX by allowing them to research DRRX shares outstanding history as well as any other stock in our coverage universe. |
| DRRX Current Stock Quote |
Quotes delayed 20 minutes  Free DRRX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| DRRX Share Performance |
| Shares Outstanding Peers |
| Durect (DRRX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
DSGN Shares Outstanding History DTIL Shares Outstanding History DVA Shares Outstanding History DVAX Shares Outstanding History DVCR Shares Outstanding History DWTX Shares Outstanding History DXCM Shares Outstanding History DYAI Shares Outstanding History DYN Shares Outstanding History DYNT Shares Outstanding History More Healthcare companies » |
DRRX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
